ASP3652
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pharmacokinetics
Conditions
Pharmacokinetics, Pharmacodynamics, Healthy Subjects, Effect of Race
Trial Timeline
Jul 1, 2012 → Sep 1, 2012
NCT ID
NCT01958047About ASP3652
ASP3652 is a phase 1 stage product being developed by Astellas Pharma for Pharmacokinetics. The current trial status is completed. This product is registered under clinical trial identifier NCT01958047. Target conditions include Pharmacokinetics, Pharmacodynamics, Healthy Subjects.
What happened to similar drugs?
5 of 5 similar drugs in Pharmacokinetics were approved
Approved (5) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02034734 | Phase 1 | Completed |
| NCT01958047 | Phase 1 | Completed |
| NCT02046798 | Phase 1 | Completed |
Competing Products
20 competing products in Pharmacokinetics